Pfizer/BioNTech Covid-19 vaccine safe for primary schoolkids


By AGENCY

Clinical trial results have demonstrated that the Pfizer-BioNTech Covid-19 vaccine is safe to be used in children aged five to 11 years. — AFP

Pfizer and BioNTech said on Sept 20 (2021) that clinical trial results showed their Covid-19 vaccine is safe and produces a robust immune response in children aged five to 11.

The vaccine would be administered at a lower dosage than for people over 12, they said.

Limited time offer:
Just RM5 per month.

Monthly Plan

RM13.90/month
RM5/month

Billed as RM5/month for the 1st 6 months then RM13.90 thereafters.

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In Health

Five things that make us happy
Working atypical hours is bad for your health
Diagnosing prostate cancer too early might cause more harm than good
Consensual 'touch interventions' boost both physical and mental health
Beware the sting of wasps and hornets as it could be fatal
Practise 'speech fasting' for heart, brain and mental benefits
Delivering drugs through the skin
Ladies, eat a Japanese diet to protect your brain
Our sense of balance is crucial to prevent falls
When loneliness triggers those sugar cravings

Others Also Read